Authors
Loading...
In vitro study demonstrates enhanced gene transfection and reduced cytotoxicity in HeLa cells using peptide-modified PAMAM dendrimers, indicating potential for targeted cancer gene therapy.
Lee et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: